TECHNOLOGY

ÃÖ°íÀÇ ±â¼ú·Â°ú Á¦Ç°À¸·Î º¸´äÇÏ´Â ºñÁö´Ï½º ÆÄÆ®³Ê°¡ µÇ°Ú½À´Ï´Ù.

±¹Ã¥°úÁ¦ ¼öÇà

[ºñƼÁø Áß¾Ó¿¬±¸¼Ò ¹× ±¹Ã¥°úÁ¦]

Ç¥¸¦ ÁÂ,¿ì·Î µå·¡±× ÇØÁÖ¼¼¿ä.
°úÁ¦¸í »ç¾÷¸í ÁÖ°üºÎó ¿¬±¸±â°£
ÀÎ»ï »çÆ÷´Ñ ºÐ¸® Á¤Á¦¸¦ À§ÇÑ »çÆ÷´ÑÀÇ ºÐ¼® ¹× ³óÃà Á¶»çÆ÷´ÑÀÇ Á¶Á¦ Àλ↓±¸°³¹ß Çѱ¹½ÄÇ°°³¹ß¿¬±¸¿ø 2003.8.1 ~ 2004.7.31
Valienamine »ó¾÷È­ ¹× ¼öÀ²Çâ»óÀ» À§ÇÑ °øÁ¤ÃÖÀûÈ­ Áß¼Ò±â¾÷±â¼úÇõ½Å°³¹ß»ç¾÷ Áß¼Ò±â¾÷û 2003.8.1 ~ 2004.7.31
¸é¿ªÁõ°¡ Çٽɹ°ÁúÀÎ Áø¼¼³ë»çÀ̵å Rg1ÀÇ ´ë·®»ý»ê¹ý °³¹ß Áß¼Ò±â¾÷±â¼úÇõ½Å°³¹ß»ç¾÷ Áß¼Ò±â¾÷û 2004.8.1 ~ 2005.5.31
Áø¼¼³ë»çÀÌµå °­È­ Ç÷´çÁ¶Àý ±â´É¼º½ÄÇ° °³¹ß »êÇÐÇù·Â »ç¾÷ ±³À°ÀÎÀûÀÚ¿øºÎ
»ê¾÷ÀÚ¿øºÎ
2004.9.1 ~ 2005.8.31
Àλï»çÆ÷´ÑÀÇ ¼ø¼öºÐ¸® ¹× Ư¼º ±Ô¸íÀ» ÅëÇÑ »óÇ°È­¿¬±¸ ³ó¸²±â¼ú°³¹ß¿¬±¸°úÁ¦ ³ó¸²ºÎ 2005.4.25 ~ 2008.4.24
¹ß±âºÎÀü Ä¡·áÈ¿°ú¸¦ °¡Áø °í³óµµ Àλï»çÆ÷´ÑÇÔÀ¯ ±â´É¼º Á¦Ç° °³¹ß Àλ¾àÃʹÙÀÌ¿À RIS
À°¼º»ç¾÷ °Ç°­±â´É¼º ¾à¸®È¿´É °ËÁõÁö¿ø »ç¾÷
³ó¸²ºÎ 2007.7.1 ~ 2008.6.30
ƯÀÌ»çÆ÷´Ñ°­È­ È«»ï³óÃà¾×ºÐ¸»ÀÇ ¾à¸®È¿´ÉÆò°¡ »êÇÐÀ¶ÇÕ¿¬±¸°úÁ¦ Çѹç´ëÇб³ 2013.9.1 ~ 2014.4.30
ƯÀÌ»çÆ÷´ÑÀÌ°­È­µÈ °íÇ°Áú ºñŸ¹ÎÀλïÀÇ °³¹ß ¹× »ó¾÷È­ Áß¼Ò±â¾÷À¶º¹ÇÕ±â¼ú°³¹ß»ç¾÷ Áß¼Ò±â¾÷û 2013.12.1 ~ 2014.11.30
Àλï»çÆ÷´Ñ Rg3°­È­ È«»ï³óÃà¾×ºÐ¸»ÀÇ
¾à¸®È¿´É(Ç×°íÇ÷¾ÐÈ¿´É)°ËÁõ ¹× Ç¥Áع°Áú °³¹ß
Áß¼Ò±â¾÷±â¼úÇõ½Å°³¹ß»ç¾÷ Áß¼Ò±â¾÷û 2013.6.20 ~ 2015.6.19
ÀλïÃßÃâºÐ¸» ´õ·çÆ®ÀÇ Ç÷¾Ð°³¼± À¯È¿¼º°ú ¾ÈÀü¼ºÀ» Æò°¡Çϱâ À§ÇÑ
À§¾à´ëÁ¶, ÀÌÁ߸ͰË, ¹«ÀÛÀ§¹èÁ¤ ÀÎüÀû¿ë½ÃÇè
2016 ½ÄÇ°±â´É¼ºÆò°¡ ÀÎüÀû¿ë½ÃÇè ³ó¸²ºÎ 2016.5.1 ~ 2017.12.31
ƯÀÌ»çÆ÷´ÑÀÌ °­È­µÈ °íÇ°Áú ºñŸ¹ÎÀλïÀÇ »ç¾÷È­ Áß¼Ò±â¾÷ ±â¼ú»ç¾÷È­Áö¿ø»ç¾÷ Áß¼Ò±â¾÷ÁøÈï°ø´Ü 2016.7.25 ~ 2016.11.11
2Çü ´ç´¢º´È¯ÀÚ¸¦ À§ÇÑ Ãµ¿¬¿ø·á ó¹æ(½ÄÀ̼¶À¯,°î¹°,Àλï)

CO-ADMINISTRATION OF FOUR COMPLIMENTARY THERAPIES
(VISCOUS DIETARY FIBER, WHOLE GRAIN AND GINSENG)
FOR COMPREHENSIVE RISK REDUCTION IN TYPE 2 DIABETES (FIbreGrainHerbTrial[FIGHT])

ij³ª´Ù´ç´¢Çùȸ Canadian Diabetes Association 2015.1.1 ~ 2018.12.31

[Áø¼¼³ë»çÀÌµå ±¸Á¶Àû º¯È¯ °úÁ¤]

TOP